London Cartilage Clinic
Explore expert articles on cartilage care, regenerative treatments, and practical recovery advice from our specialist team.
ChondroFiller, an injectable collagen scaffold, recruits the patient's own progenitor cells to rebuild cartilage across degraded knee surfaces, offering joint-preservation for advanced osteoarthritis without surgery or incision.
ChondroFiller, injected ultrasound-guided into focal cartilage lesions, polymerises within minutes into a porous hydrogel that recruits the body's stem cells for tissue regeneration. Broad knee cartilage cohorts report 81% good-to-excellent functional improvement, though outcome evidence specific to the patella remains limited.
During ordinary walking, the knee transmits three to six times body weight per step, and losing one pound removes roughly four pounds of that compressive force per stride—which explains why weight reduction is the primary structural brake on cartilage degeneration in knee osteoarthritis, independent of but complementary to exercise's anti-inflammatory and strengthening effects.
ChondroFiller injection, priced at £3,000–£8,000, uses a collagen scaffold that hardens inside the damaged joint to create a framework for the patient's repair cells to regenerate cartilage — delivering comparable outcomes to surgical repairs costing £25,000–£35,000+, yet as an outpatient procedure under local anaesthetic.
ChondroFiller is an injectable acellular collagen scaffold that recruits the patient's own cells to repair focal cartilage defects, with 70–85% of suitable patients reporting meaningful symptom relief at three to five years; available as self-funded private treatment from £3,000 in the UK.
ChondroFiller injection uses acellular collagen to recruit the patient's own repair cells into focal hip cartilage lesions, achieving regeneration in a single outpatient procedure—avoiding the cell-harvesting and two-stage implantation that traditional cartilage repair requires.
